Compare
Indivior vs Johnson & Johnson (INDV vs JNJ)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Indivior (INDV) returned +24.6% and Johnson & Johnson (JNJ) +48.5%; so far this year the figures are +1.1% and +33.5%.
Johnson & Johnson is the larger company by market value, about 155.4 times the size of Indivior.
On trailing earnings, INDV trades at 10.1 times and JNJ at 41.9 times.
Revenue grew +16.3% at INDV and +7.8% at JNJ over the last year.
INDV pays no dividend. JNJ yields 1.91%.
Data as of the latest close. Not investment advice.
Relative performance
| INDV | JNJ | |
|---|---|---|
| Price | $36.28 | $276.22 |
| 1-day | +2.57% | +1.43% |
| YTD | +1.11% | +33.47% |
| 1 year | +24.55% | +48.51% |
| 3 years | +83.23% | +85.77% |
| Market cap | $4.3B | $665.0B |
| P/E | 10.1 | 41.9 |
| P/S | 3.12 | 6.69 |
| P/B | — | 8.16 |
| Revenue growth | +16.30% | +7.80% |
| EPS growth | +254.50% | -36.40% |
| Gross margin % | 85.0 | 67.6 |
| Net margin % | 32.8 | 16.2 |
| ROE % | — | 19.7 |
| Debt / equity | — | 0.55 |
| FCF yield % | 0.7 | 3.1 |
| Dividend yield % | — | 1.91 |
| Beta | 0.63 | -0.09 |
| RSI (14) | 58.4 | 59.4 |
| Technical rating |